ClinicalTrials.gov
public full text
Public Domain
The Efficacy and Safety of Different Doses of SY-009 in Patients With Type 2 Diabetes Mellitus
SY-009 is a novel compound that inhibits sodium glucose cotransporter-1 (SGLT-1). The preclinical and phase 1 clinical trial data support to carry out phase II clinical trial in diabetes subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Study of Safety and Efficacy of PF-04991532 in Subjects With Type 2 Diabetes#158176
- Efficacy and Safety Study of MP-513 in Patients With Type 2 Diabetes#841773
- Clinical Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LEZ763#873838
- Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus#343777
- Safety Study of TH9507 in Subjects With Stable, Type 2 Diabetes#366512
Record · ID 1172772
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive